Phloretin exerts hypoglycemic effect in streptozotocin-induced diabetic rats and improves insulin resistance in vitro

Drug Des Devel Ther. 2017 Feb 7:11:313-324. doi: 10.2147/DDDT.S127010. eCollection 2017.

Abstract

The present study investigated the possible antiobesity and hypoglycemic effects of phloretin (Ph). In an attempt to discover the hypoglycemic effect and potential mechanism of Ph, we used the streptozotocin-induced diabetic rats and (L6) myotubes. Daily oral treatment with Ph for 4 weeks significantly (P<0.05) reduced postprandial blood glucose and improved islet injury and lipid metabolism. Glucose consumption and glucose tolerance were improved by Ph via GOD-POD method. Western blot results revealed that the expression of Akt, PI3K, IRS-1, and GLUT4 were upregulated in skeletal muscle of type 2 diabetes (T2D) rats and in L6 myotubes by Ph. The immunofluorescence studies confirmed that Ph improved the translocation of GLUT4 in L6 myotubes. Ph exerted hypoglycemic effects in vivo and in vitro, hence it may play an important role in the management of diabetes.

Keywords: blood glucose consumption; diabetes; insulin sensitivity; phloretin; skeletal muscle.

MeSH terms

  • Animals
  • Blood Glucose / analysis
  • Cell Survival
  • Cells, Cultured
  • Diabetes Mellitus, Experimental / chemically induced
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / pathology
  • Glucose / administration & dosage
  • Glucose / metabolism
  • Glucose Tolerance Test
  • Hypoglycemic Agents / therapeutic use*
  • Insulin Resistance*
  • Male
  • Molecular Structure
  • Phloretin / administration & dosage
  • Phloretin / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley
  • Streptozocin

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Streptozocin
  • Glucose
  • Phloretin